“The latest research has found that the combination of Shengmai San and polymyxin B can effectively eliminate pathogenic bacteria, control infection, reduce levels of inflammatory factors, regulate immune status, and improve short-term prognosis in the treatment of carbapenem resistant gram-negative bacterial sepsis with severe acute respiratory distress syndrome.”